Twenty-nine patients with essential hypertension were studied while on their normal diets, on the sth day of a high sodium diet (around 350 mmol/day) and on the Sth day of a low sodium diet (10 mmol/day). The fall in mean arterial pressure on changing from the high sodium to the low sodium diet was 9.0 + 1.6 mrnHg and the rise in the plasma renin activity in the same period was 2.52 + 0.41 ng/ml/h, these two variables being significantly correlated (r = -0.45; P < 0.02). An infusion of saralasin was given on the sth day of the low sodium diet. A highly significant negative correlation was found between the fall in blood pressure on sodium restriction and the change in blood pressure with saralasin (r : -0.52; P < 0.005); this correlation was still significant when corrected for the severity of the hypertension (r : -0.41; P : 0.03) while it became non-significant if controlled for plasma renin activity on the low sodium diet (r : -033; NS).Theseresults provide direct evidence that the fall in blood pressure which is seen on reducing sodium intake in many patients with essential hypertension is, at least in part, directly mediated by the reactivity of the renin angiotensin system.
lntroduction
Patients and methods
Although sodium restriction reduces blood pressure in many patients with essential hlpertension [1-3], the mechanism through which it acts is not clear 14-6). In essential hypertension there is a wide range of blood pressure responserdurifig-short-term sodium restriction [7, 8] . Several authors have suggested that the fall in blood pressure with sodium restriction is related to the blunting of the renin response that occurs in many patients with essential hlpertension [7] [8] [9] [10] [11] [12] . \(e therefore conducted a study looking at the changes in blood pressure with alteration in sodium intake and looking directly at the importance of the renin system on the low sodium diet by infusing 1-Sar-8-ala-angiotensin II (saralasin), a competitive inhibitor of angiotensin II.
Twenty-nine patients with essential hypertension, referred to the Blood Pressure Unit by local family doctors, were studied. Patients with renal failure (plasma creatinine > L20 pmoVl), ischaemic heaft disease, or sgle$lsvassular elisea.s€;, rr taking oral contraceptives or any other drug were excluded from the study. Subiects either had not previously received blood pressure lowering treatment or, if they had, it was stopped 3 months prior to the study. Patients were members of alarger sample which had been previously investigated as reported elsewhere [!]; they were consecutively seen in the Blood Pressure Unit and recruited for the present study when saralasin became available. All subjects were followed 3 months in the Blood Pressure Unit on no treatment. At the end of this run-in period, subjects were admitted to the study if their supine diastolic blood pressures were greater than 90 mmHg and less than 130 mmHg. There were 13 males and'1.6 females; 22 were white and seven black. The mean age of the group was 45.9 + Z.|years (mean t s.e.m.; range21,-70years) and mean supine arterial pressurewas 730.3 + 2.5 mmHg. Informed consenr was obtained from each subiect. Patients were studied for three consecutive dietary periods: on their normal diets (approximately 150 mmol sodiudby), then on a high sodium intake (around 350 mmoVday) for 5 days, followed by a low sodium intake of 10 mmoVday for J days. High sodium diet was achieved by supplementing the normal dier wirh 20 Slow sodium tablets (CIBA 10 mmol/tablet). Low sodium diet was provided by the metabolic ward kitchen. Potassium intake was not altered for either diet. Throughout the srudy all subjects were allowed to go about their normal activities; theywere not admitted to hospital but were discouraged from vigorous exercise. During the study all patients were seen in the Blood Pressure Unit at the same time of the day, by the same nurse in the same room. Blood pressure was measured between 10 a.m. and72 noon in the same arm by nurses using semi-automatic ultrasound sphygmomanometers (Arteriosonde) [13] with attached recorder, on the final day of the normal diet and on the 5th day of high and low sodium diets. The measurements were therefore free from any observer bias. Supine and standing blbod pressures were taken as the mean value of five readings obtained at 7-2 min intervals with the patients in the corresponding positions; supine blood pressure was measured before standing blood pressure. Pulse rate was measured with a Cambridge 3048 pulse monitor. Body weight was recorded at each visit. During the study, 24 h vine collections were obtained during the last 2 days of each dietary period.
Saralasin (1-Sar-8-ala-angiotensin II), a competitive inhibitor of angiotensin II, was infused on the 5th day of the low sodium diet by using an incremental infusion of O.O5 trgkg,minfor 2O min,0.25 pgkg/minfor 20 min and finally 7.25 p.glklmin for 20 min. Parients were infused sitting upright in a chair which could, if necessary, be tipped back, with a L h control period before and after infusion. Blood pressure was measured every 1-3 min with an Arteriosonde. Blood was taken in fasting conditions, without stasis, after the patient had been sining upright for l0 min between 10 a.m. and 12 noon, for electrolltes, urea, creatinine and plasma renin activity on the last day of the normal, high and low sodium diets. On the 5th day of the low sodium diet, plasma renin activity was measured by radio-immunoassay [14] before saralasin infusion. Mean arterial pressure was calculated as diastolic pressure plus one-third of pulse pressure. The blood pressure response to saralasin was calculated as the change in mean arterial pressure between rhe 20 min before infusion and the last 10 min at the highest rate of infusion. As plasma renin activity levels are known to be distributed abnormally in the population, Iog transformation of the values was used. Student's rwo-tailed paired t-tesrs, simple and partial correlation analyses were carried out using the University of London computer and the Nonh Westem Universities'Statistical Package for the Social Sciences.
Results
On their normal diets, the mean supine arterial pressure in the 29 patiens was 130.3 + 2.5 mmHg, the mean urinary sodium excretion was 155.8 + lO.Z mmol/24 h and mean plasma renin activitywas 0.95 + 0.14 ng/ml/h. On the 5th day of the high sodium diet there wzrs no significant change in the mean supine afterial pressure (129.9 + 2.4 mmHg), urinary sodium excretion rose to a mean of 287.2 + 16.0 mmoU24 h and plasma renin activityfell to 0.50 + 0.09 nglml/h. Measuremenrs on the 5th day of the low sodium diet showed rhat the mean supine arterial pressure fell to 720,9 + 2.0 mmHg,. mean urinary sodium excretion was 18.5 + 1,.7 mmoll24: h and mean plasma renin activity rose significantly to 3.03 + O.41 ng/ml/h (P < 0.001). The mean fall in blood pressure from high to low sodium diet was 9.0 + 1..6 mmHg (P < 0.001). A significant negadve correlation was found berween the fall in blood pressure on low sodium diet and the rise in plasma renin activitF 7r : -0.45; P < O.02; Fig. 1 ). Full details of systolic and diastolic blood pressure changes and other variables that were measured are shown in Table 1 .
Rise in plasma renin activity (ng/ml/h) Results given as mean + s.e.m. *p < 0.05; -.P < 0,001, for differences between effects of low sodium diet and both high sodium diet and normal diet.
tp < 0.005; ++P < 0.001, for differences between effects of high sodium diet and normal diet.
t Before saralasin infusion, on the last day of the low sodium diet, mean sitting arterial pressure was 120.7 + 2.0 mmHg and during the last 10 min of maximal infusion rate the value fell to 1t6.8 + 2.9 mmHg (r < 0.05); individual changes ranged from -26.7 to *11.7 mmHg (Fig. 2) . The change in blood pressure with saralasin on the low sodium diet showed a highly significant correlation with the fall in blood pressure on going from high to low sodium diet (r : Saralasin (1.251t1/kg/min) 150 Fig. 2 . Blood pressure response to saralasin infusion (5th day of 10 mmol Na* diet) in 29 patients with essential hypertension (mean + s.e.m.; *P < 0.05).
-o.52; P < 0.005), thus indicating that the greater the fall in blood pressure on sodium restriction, the less the fall in blood pressure with saralasin (Fig. 3) . There was also a highly significant correlation between the blood pressure fall with saralasin and the plasma renin activity on the low sodium diet (r : 0.71;P < 0.001; Fig. 4 ), as well as for the rise in plasma renin activity on going from high to low sodium diet (r = 0.72; P < 0.001). The severity of hypertension (mean blood pressure on normal diet) was also related to the blood pressure sensitivity to sodium restriction (r = O.43; P ( 0.02), to the blood pressure changes with saralasin (r : -0.41; P < 0.05) and to changes in plasma renin activity on going from high to low sodium diet (r : -O.44; P < O.O2). To rule out any spurious correlation, because of the close interrelationships among these variables, a partial correlation analysis was carried out. This analysis showed that the relationship between sodium sensitivify (considered as blood pressure fall on sodium restriction) and blood pressure change during saralasin infusion was still significant when controlled for the severity of hypertension (r : -0.47;p : g.gl) while it was no longer significant if corrected for the rise in plasma renin activity from the high to the low sodium diet (r: -0.35; NS).
Discussion
Sodium restriction reduces blood pressure in many patients with essential hypertension [1-3] and appears to be more effective the higher the blood pressure [11] ; nevertheless, the mechanism whereby it lowers blood pressure is not clear. Alteration in sodium intake causes linle change in blood pressure in normotensive subjects [11] . Several authors have pointed out that the blood pressure response to a reduction of sodium intake could be partly explained by a decreased responsiveness ofthe renin-angiotensin system [7] [8] [9] [10] [11] [12] 151 . Some studies have shown that patients with the grearesr fall in blood pressure with sodium restriction have the least rise in plasma renin activity [9] . This inverse relationship might suggest drat in essential hypertension a blunted response of the renin-angiotensin system to sodium restriction lea<isto a-gr@ rhese pafi ents. Epidemiological evidence has shown that on a normal sodium diet, the higher the blood pressure, the lower the plasma renin activiw [16] .
Chinn et al. t17l demonstrated that circulating angiotensin II, both in normal subjects and in patients with essential hypertension, is within the range that is known to modulate arterial pressure directly. Posternack et al. [78) demonstratecl that angiotensin II plays an active role in sustaining normal blood pressure under conditions of considerable sodium depletion. MacGregor et al. Il9l also provided evidence, using a converring enzyme inhibitor (Captopril) , that the renin angiorensin system maintains blood pressure in normotensive subjects on a normal sodium intake. The importance of the compensatory rise of plasma renin activity and angiotensin II in the maintenance of blood pressure in normotensive subjects was also demonstrated by a greater fall in blood pressure wirh captopril in these normotensive subjects on a low sodium diet [20] . pressor sensitivity to angiotensin II is known to decrease with reduction in sodium intake and to vary between padents, thus complicating the relationship found between measurements of the activity of the renin-angiotensin system and the blood pressure fall with sodium restriction [21] .
Saralasin is a competitive inhibitor of angiotensin II but it has agonist activity, when angiotensin II levels are low 122,231. Using an incremental infusion rate up to a maximum of 1..25 p.gA<glmin and infusing parients while sitting upright may minimize this agonist aaivity. As --,i
shon-term infusion, saralasin blocks only the immediat, effects of circulating angiotensin IL Therefore, saralasin will underesrimate the participation of the renin system in the maintenance of blood pressure. Nevertheless, it accurately reflects the relative importance of the renin system in sustaining blood pressure when comparing different individuals and will allow for differenies in sensitivity to angiotensin II between patients. In our study, the fall in blood pressure with saralasin was closely correlated with the plasma renin activity before the infusion, as reported by others 124,251, but more important is its inverse relation to the fall in blood pressure with sodium restriction. The study therefore provides direct evidence that the fall in blood pressure which is seen on reducing sodium intake in patients with essential hlpertension is, at least in part, directly mediated by the reactivity of the renin s)stem and the degree of rise of angiotensin II. This decreased responsiveness of the renin system in many patients with essential hypertension may account for the greater decrease in blood pressure on reduction of sodiu j intake seen in hypenensive patients compared t<t normotensive subjects [9] . It may also explain the differences observed by some [7,S] in the sensirivity of hwenensive patienm to sodium restriction. Patients with essential hypertension tend to have a level of plasma renin activity below that observed in age-matched normotensive subjects [26] , although there appears to be a continuous distribution of plasma renin activitywithout any division into distino populations [27, 28] . Hypertensive patients with a low plasma renin activity are resistant to eleVation ofBl@l stimuli [29, 301 . Severity of hypertension has been closely related to blood pressure sensitivity to sodium restriction [9, 12] , but this is likely to be mediated by the lowered responsiveness of the renin-angiotensin system as blood pressure rises [16] . Other mechanisms have also been proposed as involved in blood pressure sensitivity to alteration of sodium intake. The activation of the sympathetic nervous sysrem may possibly limit the fall in blood pressure during sodium restriction, in view of an increase in plasma noradrenaline found by some investigators I3I-341 in normorensive subjects, although there do not appear to be any reports in hypenensive subjects. Changes in the level of a circulating sodium
